Security
CVSA · Covista Inc.
CVSANYSECommon stockCurrentCIK 730464Updated Sep 25, 2026
Name history
Adtalem Global Education Inc. · through Jan 28, 2026Adtalem Global Education · through May 24, 2017DEVRY EDUCATION GROUP INC. · through May 15, 2017DEVRY EDUCATION GROUP · through Nov 5, 2013DEVRY INC · through Nov 5, 2013
CVSA price & chart
Loading TradingView…
NYSE:CVSA on TradingView ↗About the company
Covista (NYSE: CVSA) is America's largest healthcare educator, serving 100,000 students and supported by a community of 400,000 alumni across five accredited institutions. Through personalized, tech-enabled education powered by 10,000 faculty and colleagues, Covista expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale. Covista is the parent company of American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. For more information, visit Covista.com and follow us on LinkedIn, Instagram and YouTube.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 3,012,708,000Source | 2,752,352,000Source | 2,741,417,000Source | 2,810,541,000Source |
| Property, Plant and Equipment, NetUSD | 302,649,000Source | 256,131,000Source | 248,524,000Source | 258,522,000Source |
| GoodwillUSD | 961,262,000Source | 961,262,000Source | 961,262,000Source | 961,262,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 754,254,000Source | 765,474,000Source | 776,694,000Source | 812,338,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 406,316,000Source | 199,601,000Source | 219,306,000Source | 273,689,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 166,851,000Source | 143,433,000Source | 124,070,000Source | 100,128,000Source |
| Assets, CurrentUSD | 652,441,000Source | 416,190,000Source | 418,085,000Source | 478,539,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 75,126,000Source | 68,837,000Source | 70,050,000Source | 100,715,000Source |
| Operating Lease, Right-of-Use AssetUSD | 204,364,000Source | 191,194,000Source | 176,755,000Source | 174,677,000Source |
| Other Assets, NoncurrentUSD | 137,738,000Source | 129,145,000Source | 103,184,000Source | 68,509,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 1,566,523,000Source | 1,318,727,000Source | 1,372,282,000Source | 1,353,205,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 848,000Source | 839,000Source | 832,000Source | 822,000Source |
| Retained Earnings (Accumulated Deficit)USD | 3,029,140,000Source | 2,777,574,000Source | 2,540,509,000Source | 2,403,750,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -2,227,000Source | -2,227,000Source | -2,227,000Source | -2,227,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,446,185,000Source | 1,433,625,000Source | 1,369,135,000Source | 1,457,336,000Source |
| Additional Paid in Capital, Common StockUSD | 706,908,000Source | 664,300,000Source | 611,949,000Source | 568,761,000Source |
| Liabilities and EquityUSD | 3,012,708,000Source | 2,752,352,000Source | 2,741,417,000Source | 2,810,541,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 596,820,000Source | 507,927,000Source | 487,657,000Source | 431,203,000Source |
| Operating Lease, Liability, CurrentUSD | 34,799,000Source | 35,159,000Source | 31,429,000Source | 37,673,000Source |
| Accounts Payable, CurrentUSD | 124,763,000Source | 105,017,000Source | 102,626,000Source | 81,812,000Source |
| Operating Lease, Liability, NoncurrentUSD | 207,846,000Source | 186,172,000Source | 167,712,000Source | 163,441,000Source |
| Deferred Income Tax Liabilities, NetUSD | 61,782,000Source | 31,856,000Source | 29,526,000Source | 26,068,000Source |
| Other Liabilities, NoncurrentUSD | 42,325,000Source | 40,103,000Source | 38,675,000Source | 37,416,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 94,364,000Source | 77,286,000Source | 96,957,000Source | 105,806,000Source |
| Deferred Revenue, CurrentUSD | 259,125,000Source | 214,091,000Source | 185,272,000Source | 153,871,000Source |
| Deferred Revenue, NoncurrentUSD | 30,900,000Source | 25,000,000Source | 19,600,000Source | 10,400,000Source |
| Deferred Tax Liabilities, NetUSD | 61,782,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 552,669,000Source | 648,712,000Source | 695,077,000Source |
| Long-term Debt, Current MaturitiesUSD | 5,100,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 657,750,000Source | 552,669,000Source | 648,712,000Source | 695,077,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 251,566,000Source | 237,065,000Source | 136,777,000Source | 93,358,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 41,216,000Source | 41,590,000Source | 25,947,000Source | 14,299,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 89,263,000Source | 80,820,000Source | 76,355,000Source | 37,614,000Source |
| Increase (Decrease) in Accounts PayableUSD | 6,192,000Source | 140,000Source | 18,330,000Source | 21,666,000Source |
| Deferred Income Tax Expense (Benefit)USD | 68,352,000Source | 18,413,000Source | 11,073,000Source | -4,916,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 470,422,000Source | 337,899,000Source | 295,775,000Source | 202,908,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | 0Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -83,700,000Source | -41,921,000Source | -47,850,000Source | 12,745,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 77,696,000Source | 50,327,000Source | 48,893,000Source | 37,008,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 42,367,000Source | 14,200,000Source | 7,731,000Source | 4,592,000Source |
| Payments for Repurchase of Common StockUSD | 239,866,000Source | 213,125,000Source | 261,966,000Source | 123,133,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -180,132,000Source | -316,016,000Source | -301,798,000Source | -288,515,000Source |
| Repayments of Long-term DebtUSD | 895,283,000Source | 109,873,000Source | 51,896,000Source | 150,861,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 206,590,000Source | -20,038,000Source | -53,873,000Source | -72,862,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | 275,075,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 44,841,000Source | 46,596,000Source | 57,842,000Source | 53,126,000Source |
| Income Taxes Paid, NetUSD | 13,649,000Source | 32,777,000Source | 31,475,000Source | 12,312,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 41,216,000Source | 41,590,000Source | 25,947,000Source | 14,299,000Source |
| Amortization of Debt Issuance CostsUSD | 7,621,000Source | 5,985,000Source | 5,663,000Source | 9,129,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 2,920,000Source | 4,247,000Source | 4,550,000Source | 4,832,000Source |
| Amortization of Intangible AssetsUSD | 11,220,000Source | 11,220,000Source | 35,644,000Source | 61,239,000Source |
| DepreciationUSD | 43,850,000Source | 40,702,000Source | 39,676,000Source | 41,575,000Source |
| Gain (Loss) on InvestmentsUSD | 1,720,000Source | 1,074,000Source | 1,365,000Source | -3,689,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 0Source | 0Source | 13,317,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | -4,810,000Source | 0Source | 0Source | 71,000Source |
| GoodwillUSD | 961,262,000Source | 961,262,000Source | 961,262,000Source | 961,262,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 267,375,000Source | 232,677,000Source | 137,713,000Source | 101,752,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -15,809,000Source | 4,388,000Source | -936,000Source | -8,394,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -15,809,000Source | 4,388,000Source | -936,000Source | -8,394,000Source |
| Income Tax Expense (Benefit)USD | 77,744,000Source | 65,837,000Source | 26,224,000Source | 10,283,000Source |
| Net Income (Loss) Attributable to ParentUSD | 251,566,000Source | 237,065,000Source | 136,777,000Source | 93,358,000Source |
| Other Nonoperating Income (Expense)USD | 7,178,000Source | 9,290,000Source | 10,542,000Source | 6,965,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 1,007,450,000Source | 9,873,000Source | 1,896,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 131,000Source | 10,027,000Source | 17,089,000Source | 2,625,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | 1,536,000Source | 1,940,000Source | 2,938,000Source | 3,640,000Source |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 1,954,085,000Source | 1,788,290,000Source | 1,584,652,000Source | 1,450,826,000Source |
| Cost of RevenueUSD | 833,660,000Source | 771,430,000Source | 698,548,000Source | 648,486,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 730,720,000Source | 672,004,000Source | 632,965,000Source | 586,009,000Source |
| Operating Income (Loss)USD | 383,376,000Source | 341,542,000Source | 217,054,000Source | 168,170,000Source |
| Other Nonoperating Income (Expense)USD | 7,178,000Source | 9,290,000Source | 10,542,000Source | 6,965,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 345,119,000Source | 298,514,000Source | 163,937,000Source | 112,035,000Source |
| Income Tax Expense (Benefit)USD | 77,744,000Source | 65,837,000Source | 26,224,000Source | 10,283,000Source |
| Net Income (Loss) Attributable to ParentUSD | 251,566,000Source | 237,065,000Source | 136,777,000Source | 93,358,000Source |
| Earnings Per Share, BasicUSD per share | 7.18Source | 6.39Source | 3.47Source | 2.08Source |
| Earnings Per Share, DilutedUSD per share | 7.04Source | 6.18Source | 3.39Source | 2.05Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 35,045,000Source | 37,085,000Source | 39,413,000Source | 44,781,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 35,715,000Source | 38,334,000Source | 40,307,000Source | 45,600,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 11,220,000Source | 11,220,000Source | 35,644,000Source | 61,239,000Source |
| Costs and ExpensesUSD | 1,570,709,000Source | 1,446,748,000Source | 1,367,598,000Source | 1,282,656,000Source |
| Current Income Tax Expense (Benefit)USD | 9,392,000Source | 47,424,000Source | 15,151,000Source | 15,199,000Source |
| Gain (Loss) on InvestmentsUSD | 1,720,000Source | 1,074,000Source | 1,365,000Source | -3,689,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 267,375,000Source | 232,677,000Source | 137,713,000Source | 101,752,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 254,316,000Source | 221,225,000Source | 89,752,000Source | 51,422,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 7.63Source | 6.27Source | 3.49Source | 2.27Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 7.49Source | 6.07Source | 3.42Source | 2.23Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -15,809,000Source | 4,388,000Source | -936,000Source | -8,394,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -15,809,000Source | 4,388,000Source | -936,000Source | -8,394,000Source |
| Interest ExpenseUSD | 45,435,000Source | 52,318,000Source | 63,659,000Source | 63,100,000Source |
| Interest Expense, DebtUSD | 45,435,000Source | 52,318,000Source | 63,659,000Source | 63,100,000Source |
Filing attachments
cvsa-20260806xex99d1.htm · 8-K · 2026-08-06
EX-99.1 2 cvsa-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor. Relations@Covista.com +1 312-906-6600 Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance Total Q4 enrollment up 8.4% and revenue up 9.7% YoY Chamberlain accelerates total enrollment growth to 1.6% Revenue up 9.3% YoY for fiscal year 2026 Fiscal year 2026 dil…
Read attachment ↗cvsa-20260728xex99d1.htm · 8-K · 2026-07-28
EX-99.1 2 cvsa-20260728xex99d1.htm EX-99.1 Exhibit 99.1 Covista Names Emily C. Chiu and Leslie Storms to its Board of Directors Appointments Deepen the Board’s Expertise Across Healthcare Delivery, Technology, Higher Education and Veterinary Medicine Supports Effective Oversight of the Company’s Growth and Long-Term Strategy CHICAGO – JULY 28, 2026 – Covista (NYSE: CVSA), America's largest healthcare educator, today announced the appointments of Emily C. Chiu and Leslie Storms…
Read attachment ↗cvsa-20260507xex99d1.htm · 8-K · 2026-05-07
EX-99.1 2 cvsa-20260507xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor. Relations@Covista.com +1 312-906-6600 Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Third Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Revenue and Adjusted Earnings Per Share Guidance Total enrollment up 6.8% YoY, with Chamberlain returning to positive total enrollment growth Surpassed 100,000 students including record enrollment at Chamber…
Read attachment ↗cvsa-20260409xex99d1.htm · 8-K · 2026-04-09
EX-99.1 2 cvsa-20260409xex99d1.htm EX-99.1 Exhibit 99.1 The U.S. healthcare workforce shortage requires more than just growing the supply through strong education, it also must solve the access problem, particularly in some of the most underserved areas like rural communities. This requires collaboration across the entire healthcare ecosystem. In February, Covista announced it was a founding member of the Alliance for Advancing Rural Healthcare (AARH), bringing together a co…
Read attachment ↗cvsa-20260302xex4d1.htm · 8-K · 2026-03-03
EX-4.1 2 cvsa-20260302xex4d1.htm EX-4.1 Exhibit 4.1 Execution Version AMENDMENT NO. 5 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT This AMENDMENT NO. 5 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT (this “Agreement”), dated as of March 2, 2026, is made by and among Covista Inc. (formerly known as Adtalem Global Education Inc.), a Delaware corporation (the “Borrower”), the Loan Parties party hereto, Morgan Stanley Senior Funding, Inc. (“MSSF”), as Admin…
Read attachment ↗cvsa-20260224xex99d1.htm · 8-K · 2026-02-24
EX-99.1 2 cvsa-20260224xex99d1.htm EX-99.1 Exhibit 99.1 Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day Introduces Purpose at Scale, the company’s next three-year growth strategy to address one of healthcare’s most significant challenges Announces financial targets for fiscal year 2027 through fiscal year 2029 Reaffirms fiscal year 2026 guidance and provides updates on strategic priorities and institutional performance CHICAGO - Feb. 24…
Read attachment ↗